Clinical trial
Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults
NCT00387738 · Dynavax Technologies Corporation, Industry · Terminated
Key facts
| NCT number | NCT00387738 |
|---|---|
| Title | Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults |
| Official title | A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Dose-Regimen Study of the Efficacy and Safety of TOLAMBA™ in Ragweed-Allergic Rhinitis Adults |
| Lead sponsor | Dynavax Technologies Corporation, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Biological |
| Interventions | Amb a 1 immunostimulatory oligodeoxyribonucleotide conjugate, Histamine base |
| Enrollment | 738 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Oct 13, 2006 |
| Last update posted | Apr 16, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: